The Prevalence and Outcome of Acute Hypoxemic Respiratory Failure (PANDORA) Study in Mechanically Ventilated Children: Prospective Multicenter Epidemiology in Spain, 2019-2021
- PMID: 40277417
- DOI: 10.1097/PCC.0000000000003743
The Prevalence and Outcome of Acute Hypoxemic Respiratory Failure (PANDORA) Study in Mechanically Ventilated Children: Prospective Multicenter Epidemiology in Spain, 2019-2021
Abstract
Objectives: To describe the epidemiology and outcome of children with acute hypoxemic respiratory failure (AHRF) and/or pediatric acute respiratory distress syndrome (PARDS).
Design: Prospective, observational study in six nonconsecutive 2-month blocks form October 2019 to September 2021.
Setting: A network of 22 PICUs in Spain.
Patients: Consecutive children (7 d to 15 yr old) with a diagnosis of AHRF, defined by Pa o2 /F io2 ratio less than or equal to 300 mm Hg, who needed invasive mechanical ventilation (IMV) using positive end-expiratory pressure (PEEP) greater than or equal to 5 cm H 2 O and F io2 greater than or equal to 0.3.
Interventions: None.
Measurements and main results: The primary outcomes were AHRF prevalence and PICU mortality. The secondary outcomes were the prevalence of IMV with PARDS (IMV-PARDS) and the use of adjunctive therapies. There were 6545 PICU admissions: 1374 (21%) underwent IMV and 181 (2.8%) had AHRF. Ninety-one patients (1.4% of PICU admissions, 6.6% of IMV cases, and 50.3% of AHRF cases) met the Second Pediatric Acute Lung Injury Consensus Conference IMV-PARDS criteria. At baseline, mean (± sd ) tidal volume was 7.4 ± 1.8 mL/kg ideal body weight, PEEP 8.4 ± 3.1 cm H 2 O, F io2 0.68 ± 0.23, and plateau pressure 25.7 ± 6.3 cm H 2 O. Unlike patients with PARDS, adjunctive therapies were used infrequently in non-PARDS AHRF patients. AHRF patients without PARDS had more ventilator-free days than PARDS patients (16.4 ± 9.4 vs. 11.2 ± 10.5; p = 0.002). All-cause PICU mortality in AHRF cases was higher in PARDS vs. non-PARDS patients (30.8% [95% CI, 21.5-41.3] vs. (14.4% [95% CI, 7.9-23.4]; p = 0.01).
Conclusions: In our 2019-2021 PICU population, the prevalence of AHRF is 2.8% of IMV cases. Of such patients, the prevalence of PARDS was 50.3%, and there was a 30.8% mortality, which was higher than in cases of AHRF without PARDS.
Trial registration: ClinicalTrials.gov NCT04791501.
Keywords: acute hypoxemic respiratory failure; acute respiratory distress syndrome; children; epidemiology; lung-protective ventilation.
Copyright © 2025 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Conflict of interest statement
Dr. López-Fernández received a grant from Instituto de Salud Carlos III, Madrid, Spain (PI19/00141). Dr. Villar received grants from Instituto de Salud Carlos III, Madrid, Spain (No. CB06/06/1088, PI19/00141, AC_212/00039), ERA PerMed (JTC_2021), The European Regional Development Funds, Fundación Canaria Instituto de Investigación Sanitaria de Canarias, Spain, and Asociación Científica Pulmón y Ventilación Mecánica, Spain. Dr. Gómez-Zamora received funding from AEROGEN(R). Dr. Szakmany has disclosed that he is Trustee of the Intensive Care National Audit and Research Centre (United Kingdom) Congress Co-Chair 2024 Society of Critical Care Medicine Congress. The remaining authors have disclosed that they do not have any potential conflicts of interest.
References
-
- World Medical Association: World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013; 310:2191–2194
-
- von EE, Altman DG, Egger M, et al.: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ. 2007; 335:806–808
-
- Emeriaud G, López-Fernández YM, Lyer NP, et al.; Second Pediatric Acute Lung Injury Consensus Conference (PALICC-2) Group on behalf of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network: Executive summary of the second international guidelines for the diagnosis and management of pediatric acute respiratory distress syndrome (PALICC-2). Pediatr Crit Care Med. 2023; 24:143–168
-
- Grunwell JR, Dahmer MK, Sapru A, et al.; Second Pediatric Acute Lung Injury Consensus Conference (PALICC-2) for the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network: Pathobiology, severity, and risk stratification of pediatric acute respiratory distress syndrome: From the Second Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2023; 24:S12–S27
-
- Killien EY, Maddux AB, Tse SM, et al.; Second Pediatric Acute Lung Injury Consensus Conference (PALICC-2) of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network: Outcomes of children surviving pediatric acute respiratory distress syndrome: From the Second Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2023; 24:S28–S44
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
